Literature DB >> 26496698

Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model.

Jaime Henrique Amorim1, Rúbens Prince dos Santos Alves2, Raíza Bizerra2, Sara Araújo Pereira2, Lennon Ramos Pereira2, Denicar Lina Nascimento Fabris2, Robert Andreata Santos2, Camila Malta Romano3, Luís Carlos de Souza Ferreira4.   

Abstract

Generating neutralizing antibodies have been considered a prerequisite to control dengue virus (DENV) infection. However, T lymphocytes have also been shown to be important in a protective immune state. In order to investigate the contribution of both humoral and cellular immune responses in DENV immunity, we used an experimental model in which a non-lethal DENV2 strain (ACS46) is used to intracranially prime Balb/C mice which develop protective immunity against a lethal DENV2 strain (JHA1). Primed mice generated envelope-specific antibodies and CD8(+) T cell responses targeting mainly non-structural proteins. Immune sera from protected mice did not confer passive protection to naïve mice challenged with the JHA1 strain. In contrast, depletion of CD4(+) and CD8(+) T lymphocytes significantly reduced survival of ACS46-primed mice challenged with the JHA1 strain. Collectively, results presented in this study show that a cellular immune response targeting non-structural proteins are a promising way in vaccine development against dengue.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibodies; Dengue; Immune response; Nonstructural proteins; T lymphocytes

Mesh:

Substances:

Year:  2015        PMID: 26496698     DOI: 10.1016/j.virol.2015.10.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.

Authors:  Rúbens Prince Dos Santos Alves; Lennon Ramos Pereira; Denicar Lina Nascimento Fabris; Felipe Scassi Salvador; Robert Andreata Santos; Paolo Marinho de Andrade Zanotto; Camila Malta Romano; Jaime Henrique Amorim; Luís Carlos de Souza Ferreira
Journal:  Clin Vaccine Immunol       Date:  2016-06-06

2.  Microglia retard dengue virus-induced acute viral encephalitis.

Authors:  Tsung-Ting Tsai; Chia-Ling Chen; Yee-Shin Lin; Chih-Peng Chang; Cheng-Chieh Tsai; Yi-Lin Cheng; Chao-Ching Huang; Chien-Jung Ho; Yi-Chao Lee; Liang-Tzung Lin; Ming-Kai Jhan; Chiou-Feng Lin
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

3.  A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates.

Authors:  Gokul Swaminathan; Elizabeth A Thoryk; Kara S Cox; Jeffrey S Smith; Jayanthi J Wolf; Marian E Gindy; Danilo R Casimiro; Andrew J Bett
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

4.  In silico design of a Zika virus non-structural protein 5 aiming vaccine protection against zika and dengue in different human populations.

Authors:  Lorrany Dos Santos Franco; Paloma Oliveira Vidal; Jaime Henrique Amorim
Journal:  J Biomed Sci       Date:  2017-11-23       Impact factor: 8.410

5.  The Role of Heterotypic DENV-specific CD8+T Lymphocytes in an Immunocompetent Mouse Model of Secondary Dengue Virus Infection.

Authors:  Laura B Talarico; Juan P Batalle; Alana B Byrne; Jorge M Brahamian; Adrián Ferretti; Ayelén G García; Aldana Mauri; Carla Simonetto; Diego R Hijano; Andrea Lawrence; Patricio L Acosta; Mauricio T Caballero; Yésica Paredes Rojas; Lorena I Ibañez; Guillermina A Melendi; Félix A Rey; Elsa B Damonte; Eva Harris; Fernando P Polack
Journal:  EBioMedicine       Date:  2017-04-27       Impact factor: 8.143

6.  Seeking Flavivirus Cross-Protective Immunity.

Authors:  Lorrany Dos Santos Franco; Letícia Tsieme Gushi; Wilson Barros Luiz; Jaime Henrique Amorim
Journal:  Front Immunol       Date:  2019-09-20       Impact factor: 7.561

Review 7.  Contribution of Resident Memory CD8+ T Cells to Protective Immunity Against Respiratory Syncytial Virus and Their Impact on Vaccine Design.

Authors:  Angello Retamal-Díaz; Camila Covián; Gaspar A Pacheco; Angelo T Castiglione-Matamala; Susan M Bueno; Pablo A González; Alexis M Kalergis
Journal:  Pathogens       Date:  2019-09-11

Review 8.  Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?

Authors:  Lucas Wilken; Guus F Rimmelzwaan
Journal:  Pathogens       Date:  2020-06-15

9.  Quantification of dengue virus specific T cell responses and correlation with viral load and clinical disease severity in acute dengue infection.

Authors:  Dulharie T Wijeratne; Samitha Fernando; Laksiri Gomes; Chandima Jeewandara; Anushka Ginneliya; Supun Samarasekara; Ananda Wijewickrama; Clare S Hardman; Graham S Ogg; Gathsaurie Neelika Malavige
Journal:  PLoS Negl Trop Dis       Date:  2018-10-01

Review 10.  Two Is Better Than One: Evidence for T-Cell Cross-Protection Between Dengue and Zika and Implications on Vaccine Design.

Authors:  Krishanthi S Subramaniam; Suzannah Lant; Lynsey Goodwin; Alba Grifoni; Daniela Weiskopf; Lance Turtle
Journal:  Front Immunol       Date:  2020-03-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.